VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Kiniksa Pharmaceuticals International, plc (KNSA) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $7.2B · P/E 71.2 · revenue $946M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows